Gene · 10935
Papers2,082
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,082
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Endonuclease G binding protein using a method which specifically isolates binding partners within subcellular compartments. | Mol Cell Proteomics | 2026 | 42815854 | PubTator, text mining | PubMed |
Pramipexole enhances levodopa's therapeutic efficacy in Parkinson's disease: Role of glutaredoxin-1 (GRX1), peroxiredoxin3 (PRX3), thioredoxin (TRX), 8-hydroxy-2 -deoxyguanosine (8-OHDG), and neurosteroid dehydroepiandrosterone sulfate (DHEA-S). | J Med Biochem | 2026 | 42775310 | PubTator, text mining | PubMed |
| Aged Mitochondrial DNA Is Associated With Aberrant Acute Exercise-Induced Redox Responses in Human Skeletal Muscle. | Aging Cell | 2026 | 42625404 | PubTator, text mining | PubMed |
| Clinical features of four unrelated Japanese patients with autosomal recessive spinocerebellar ataxia type 32. | J Hum Genet | 2026 | 42608543 | PubTator, text mining | PubMed |
| Design, synthesis, and antitumor evaluation of celastrol derivatives targeting PRDX3. | Eur J Med Chem | 2026 | 42594679 | PubTator, text mining | PubMed |
| Up-regulation of peroxiredoxin 3 by high-risk human papillomavirus in cervical cancer cells. | Arch Med Sci | 2026 | 42540497 | PubTator, text mining | PubMed |
| Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer. | Nat Commun | 2026 | 42448681 | PubTator, text mining | PubMed |
| Erianin ameliorates liver fibrosis through the PRDX3/NLRX1 axis. | Eur J Pharmacol | 2026 | 42392250 | PubTator, text mining | PubMed |
| Extracellular Vesicles From Young Brain-Mediated Delivery of PRDX3 Ameliorates Alveolar Bone Loss in Periodontitis. | J Clin Periodontol | 2026 | 42375016 | PubTator, text mining | PubMed |
| Identification of Hub Genes, Single-Nucleotide Polymorphisms, and Potential Drug Targets In Breast Cancer Using Transcriptomic Analysis. | J Vis Exp | 2026 | 42372043 | PubTator, text mining | PubMed |
| Phenotyping of post-fertilization sperm mitophagy determinants discovered in a mammalian gamete-based cell-free system. | Biol Res | 2026 | 42366378 | PubTator, text mining | PubMed |
| RNASET2 degrades mRNAs that protect against lipotoxicity. | Mol Metab | 2026 | 42349552 | PubTator, text mining | PubMed |
| Cadmium exposure activates ferroptosis through downregulated PPARγ expression in preeclampsia placenta. | Toxicology | 2026 | 42263808 | PubTator, text mining | PubMed |
| Isoform-specific expression of peroxiredoxins in human cancer cell lines with various radioresistance. | Free Radic Res | 2026 | 42172000 | PubTator, text mining | PubMed |
| The integrated analysis of PRDX3 in lung cancer: biomarker potential and therapeutic target prospects. | Respir Res | 2026 | 42092925 | PubTator, text mining | PubMed |
| Detecting ferroptotic cells using an antibody against hyperoxidized PRDX3. | Methods Cell Biol | 2026 | 42062006 | PubTator, text mining | PubMed |
| Hepatic transcriptomic responses in gravid and non-gravid rats exposed to HFPO-DA: Analyses to inform the role of maternal effects in neonatal toxicity. | PLoS One | 2026 | 41920860 | PubTator, text mining | PubMed |
| Mitochondrial Long Non-Coding RNAs in Gynecological Cancers: Pathogenic Signaling Pathways and Therapeutic Opportunities. | Curr Issues Mol Biol | 2026 | 41899413 | PubTator, text mining | PubMed |
| CISAT, a CoPP-Induced lncRNA, Improves Cardiac Mesenchymal Progenitor Cell Survival and Myocardial Repair via SFPQ/NRF2/p38 Redox Regulation. | Cells | 2026 | 41892346 | PubTator, text mining | PubMed |
| Protein co-expression network analysis explores biological mechanisms associated with meat quality variability in broilers affected by breast myopathies: A focus on wooden breast. | Poult Sci | 2026 | 41887176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10935/papers